Free Trial

Vicarious Surgical (RBOT) Stock Price, News & Analysis

-0.03 (-7.78%)
(As of 05/21/2024 ET)
Today's Range
50-Day Range
52-Week Range
327,367 shs
Average Volume
588,853 shs
Market Capitalization
$52.34 million
P/E Ratio
Dividend Yield
Price Target

Vicarious Surgical MarketRank™ Stock Analysis

Analyst Rating
2.00 Rating Score
87.5% Upside
$0.67 Price Target
Short Interest
4.49% of Shares Sold Short
Dividend Strength
News Sentiment
0.00mentions of Vicarious Surgical in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$23,147 Sold Last Quarter
Proj. Earnings Growth
From ($0.36) to ($0.41) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.93 out of 5 stars

Medical Sector

810th out of 921 stocks

Surgical Appliances & Supplies Industry

16th out of 18 stocks

RBOT stock logo

About Vicarious Surgical Stock (NYSE:RBOT)

Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

RBOT Stock Price History

RBOT Stock News Headlines

RBOT Vicarious Surgical Inc.
Robotic interface masters a soft touch
Q4 2023 Vicarious Surgical Inc Earnings Call
Vicarious Surgical (RBOT) Gets a Hold from BTIG
Vicarious Surgical Chairman David Styka Resigns
RBOT Apr 2024 2.500 put
See More Headlines
Receive RBOT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vicarious Surgical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Surgical appliances & supplies
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
4 Analysts


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
Book Value
$0.56 per share


Free Float
Market Cap
$50.83 million
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

RBOT Stock Analysis - Frequently Asked Questions

Should I buy or sell Vicarious Surgical stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Vicarious Surgical in the last year. There are currently 4 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" RBOT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RBOT, but not buy additional shares or sell existing shares.
View RBOT analyst ratings
or view top-rated stocks.

What is Vicarious Surgical's stock price target for 2024?

4 Wall Street analysts have issued 12 month price objectives for Vicarious Surgical's stock. Their RBOT share price targets range from $0.40 to $1.00. On average, they anticipate the company's share price to reach $0.67 in the next year. This suggests a possible upside of 87.5% from the stock's current price.
View analysts price targets for RBOT
or view top-rated stocks among Wall Street analysts.

How have RBOT shares performed in 2024?

Vicarious Surgical's stock was trading at $0.3667 on January 1st, 2024. Since then, RBOT stock has decreased by 3.1% and is now trading at $0.3555.
View the best growth stocks for 2024 here

When is Vicarious Surgical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 25th 2024.
View our RBOT earnings forecast

How were Vicarious Surgical's earnings last quarter?

Vicarious Surgical Inc (NYSE:RBOT) posted its quarterly earnings data on Monday, April, 29th. The company reported ($0.09) earnings per share for the quarter, topping analysts' consensus estimates of ($0.10) by $0.01.

Who are Vicarious Surgical's major shareholders?

Vicarious Surgical's stock is owned by a number of retail and institutional investors. Top institutional investors include Jacobs Levy Equity Management Inc. (0.14%). Insiders that own company stock include Adam David Sachs, John Mazzola, June Morris, Philip Liang, Sammy Khalifa, Ventures V LP Khosla and William John Kelly.
View institutional ownership trends

How do I buy shares of Vicarious Surgical?

Shares of RBOT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:RBOT) was last updated on 5/21/2024 by Staff

From Our Partners